EP3565580
CONTINUOUS ADMINISTRATION OF EXENATIDE AND CO-ADMINSTRATION OF ACETAMINOPHEN, ETHINYLESTRADIOL OR LEVONORGESTREL
:
EP einkaleyfi: Þýðing ekki lögð inn:
3.1.2018:
6.3.2024:
18709116.0
:
2.1.2038
:
CONTINUOUS ADMINISTRATION OF EXENATIDE AND CO-ADMINSTRATION OF ACETAMINOPHEN, ETHINYLESTRADIOL OR LEVONORGESTREL
3.1.2018
6.3.2024
:
i2o Therapeutics, Inc.:
700 Main Street, Cambridge, MA 02139, US
:
BARON, Michelle:
Boston, MA 02210, US
:
YOUNG, Andrew:
Boston, MA 02210, US
:
201762441833 P:
3.1.2017:
US
:
US2018012204:
3.1.2018
:
A61K 38/26, A61K 31/37, A61K 31/40, A61K 31/401, A61K 31/565, A61K 31/567, A61K 31/7048, A61P 3/10